XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Note 2 - Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Notes Tables  
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]
   

September 30,

   

December 31,

 
   

2025

   

2024

 

Cash and cash equivalents

  $ 2,309     $ 430  

Restricted cash included in other assets

    393       477  

Total cash, cash equivalents, and restricted cash in the condensed consolidated statements of cash flows

  $ 2,702     $ 907  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Three Months Ended

September

30,

   

Nine Months Ended

September 30,

 
   

2025

   

2024

   

2025

   

2024

 

Numerator for basic and diluted income (loss) per share:

                               

Net loss from continuing operations

  $ (1,333 )   $ (1,854 )   $ (6,627 )   $ (6,852 )

Less: Increase to accumulated deficit due to adjustment to common stock warrants exercise price

          1,005             1,005  

Less: Increase to accumulated deficit due to adjustment to Preferred Stock conversion price

                      380  

Net loss from continuing operations attributable to common stockholders

  $ (1,333 )   $ (2,859 )   $ (6,627 )   $ (8,237 )

Net income from discontinued operations, net of taxes

    40       642       11,082       841  

Net (loss) income

  $ (1,293 )   $ (2,217 )   $ 4,455     $ (7,396 )
                                 

Denominator for (loss) income per share:

                               

Weighted average shares outstanding – basic (diluted for net loss)

    5,876       1,155       5,669       930  

Effect of dilutive Unsecured Convertible Notes

                107        

Weighted average shares outstanding – diluted for net income

    5,876       1,155       5,776       930  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   

As of September 30,

 
   

2025

   

2024

 

Common stock equivalent of Series B Non-Voting Convertible Preferred Stock (the “Series B Preferred Stock”)

    15       15  

Stock options

    1       7  

Stock warrants

    101       225  
      117       247